Tigecycline resistance in Serratia marcescens associated with up-regulation of the SdeXY-HasF efflux system also active against ciprofloxacin and cefpirome

Michael Hornsey, Matthew J. Ellington, Michel Doumith, Sue Hudson, David M. Livermore, Neil Woodford

Research output: Contribution to journalArticlepeer-review

36 Citations (Scopus)


Objectives Efflux by RND-type transporters is known to confer resistance to tigecycline in several Enterobacteriaceae species and we examined the potential of this mechanism in Serratia marcescens using a clinical isolate and laboratory-selected mutants. Methods Expression of RND-type efflux pump genes was analysed by real-time RT–PCR. Laboratory mutants were selected by exposure to either tigecycline or tetracycline in vitro. Efflux pump genes were inactivated by suicide plasmids containing the R6K? origin of replication. Results Higher tigecycline MICs correlated with elevated expression of the RND-type efflux pump genes sdeXY. Inactivation of sdeY or the outer membrane component gene hasF reduced MICs of tigecycline, tetracycline, ciprofloxacin and cefpirome to below those for strain NCTC 10211. A tetracycline-selected laboratory mutant also showed increases in sdeXY expression and tigecycline MIC. Conclusions Up-regulation of endogenous SdeXY–HasF-mediated efflux is associated with tigecycline resistance in S. marcescens along with MIC rises for tetracycline, ciprofloxacin and cefpirome. Inactivation of this efflux system reduced MICs of those compounds to below those for strain NCTC 10211.
Original languageEnglish
Pages (from-to)479-482
Number of pages4
JournalJournal of Antimicrobial Chemotherapy
Issue number3
Publication statusPublished - Mar 2010

Cite this